A detailed history of Verition Fund Management LLC transactions in Omeros Corp stock. As of the latest transaction made, Verition Fund Management LLC holds 100,800 shares of OMER stock, worth $607,824. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100,800
Previous 30,700 228.34%
Holding current value
$607,824
Previous $124,000 222.58%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.54 - $5.47 $54,346 - $83,975
-15,352 Reduced 42.8%
20,520 $81,000
Q2 2024

Aug 14, 2024

BUY
$3.04 - $4.23 $109,050 - $151,738
35,872 New
35,872 $145,000
Q4 2023

Feb 14, 2024

SELL
$1.08 - $3.63 $12,714 - $42,735
-11,773 Reduced 53.03%
10,427 $34,000
Q3 2023

Nov 14, 2023

BUY
$2.81 - $5.69 $62,382 - $126,318
22,200 New
22,200 $64,000
Q4 2021

Feb 14, 2022

BUY
$5.67 - $8.54 $152,523 - $229,725
26,900 New
26,900 $173,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $378M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.